Steigerwald Gordon & Koch’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$612K Hold
105,563
0.06% 80
2026
Q1
$639K Hold
105,563
0.07% 78
2025
Q4
$756K Hold
105,563
0.07% 79
2025
Q3
$797K Sell
105,563
-25,000
-19% -$182K 0.08% 78
2025
Q2
$815K Sell
130,563
-20,000
-13% -$92.5K 0.09% 69
2025
Q1
$470K Hold
150,563
0.05% 83
2024
Q4
$595K Hold
150,563
0.07% 79
2024
Q3
$610K Hold
150,563
0.07% 81
2024
Q2
$384K Hold
150,563
0.05% 88
2024
Q1
$670K Hold
150,563
0.08% 73
2023
Q4
$711K Hold
150,563
0.1% 68
2023
Q3
$732K Sell
150,563
-10,000
-6% -$61.6K 0.11% 66
2023
Q2
$963K Sell
160,563
-40,000
-20% -$189K 0.14% 56
2023
Q1
$626K Sell
200,563
-13,000
-6% -$37.1K 0.09% 70
2022
Q4
$553K Sell
213,563
-40,000
-16% -$118K 0.09% 74
2022
Q3
$538K Sell
253,563
-2,445
-1% -$6.38K 0.1% 68
2022
Q2
$681K Hold
256,008
0.12% 66
2022
Q1
$678K Buy
+256,008
New +$837K 0.1% 67

Other funds holding EVLV

Steigerwald Gordon & Koch's EVLV Position: Q2 2026 in Review

Steigerwald Gordon & Koch held its Evolv Technologies (EVLV) position steady in Q2 2026 at 105,563 shares worth $612K. The position accounts for 0.06% of the portfolio, ranked #80.

Steigerwald Gordon & Koch first reported a position in EVLV in Q1 2022 and has held it in 18 quarters since. The position peaked at $963K in Q2 2023. 260 funds tracked by Wall St. Rank hold EVLV as of Q2 2026.

  • Steigerwald Gordon & Koch held 105,563 shares of Evolv Technologies worth $612K as of Q2 2026.
  • Steigerwald Gordon & Koch left its Evolv Technologies share count unchanged in Q2 2026.
  • Evolv Technologies made up 0.06% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #80 holding.
  • Steigerwald Gordon & Koch first reported a position in Evolv Technologies in Q1 2022 and has held it in 18 quarters since.
  • Steigerwald Gordon & Koch's Evolv Technologies position peaked at $963K in Q2 2023.
  • 260 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.